Bensali, Ashyana S.

HRN: 27-82-43  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/20/2025
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
09/20/2025
09/27/2025
IV
300mg
Q6H
PCAP D
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines